Focuses on the use of vasopressin antagonists in animal studies. Role of V1 antagonists in experimental models to assess the contribution of arginine-vasopressin in cardiovascular control; Ability of the antagonist to modify several postreinfusion values; Detection of an increase in the urine volume of dehydrated rats due to the administration of V2 antagonists.